retatrutide for diabetes ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Retatrutide 10 mg — Sequentia

ACC/AHA guidelines flag levels above 2.0 mg/L as higher cardiovascular risk

Her plan includes: Adjusting her GLP-1 dose and aiming for a steadier rate of loss

In August 2025, Eli Lilly (US) announced a collaboration with a leading technology firm to integrate artificial intelligence into its drug development processes

INVITING ATMOSPHERE We have a brand-new storefront location designed for comfort and the best experience possible

I have seen hundreds of women in my own clinic, sitting across from me in paper gowns, grabbing the new weight around their middles and asking, What happened to me? For years, I gave the same advice I had been taught: eat less, move more

J Clin Pharmacol (2015) 55(2):1528